My Stocks Explore Events Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Live today
{{event.ticker}} @{{event.event_utc_datetime | date:'h:mm a'}}
{{market.market_short_name}} {{market.last_price | number : 2}}

Want to join the conversation?

$BBBY {{ '2016-06-14T10:41:12+0000' | timeago}} • SEC

$BBBY's FY15 CapEx was $328.4MM. For FY16, CapEx is expected to be about $400-425MM, with a significant part for IT enhancements including enhancements to company's digital, web and mobile capabilities and deployment of new systems and equipment to stores and other projects.

User Melwyn Jones {{ '2016-10-28T17:16:30+0000' | timeago}}

$CVX posts first profit in a year. Right time to get some shares? My question is, will it sustain this turnaround?

User Josh Allan {{ '2016-10-27T15:39:01+0000' | timeago}}

Jeff Bezos, my inspiration next to Steve Jobs is going to review the Everything Store $AMZN's financial results today after hours. As an investor/user, I like Amazon Prime and it's success over several parts of the world. What's your take on Amazon?

User RC xNair {{ '2016-10-27T13:31:32+0000' | timeago}}

Of all the Wall St firms out there, Goldman Sachs $GS is the most revered for the way they're run - hiring the best, highly competitive, a closely-knit peer group and making tons of profits for the shareholders. An interesting interview of its CEO Llyod Blankfein by Carlyle groups chief David Rubenstein

User Ramesh Raju {{ '2016-10-27T10:38:07+0000' | timeago}}

Deutsche Bank posts Q3 net profit of 278 million euros.

User Vishnu Beri {{ '2016-10-27T01:52:28+0000' | timeago}}

Great results from $TSLA, however the question remains if Tesla can continue to scale up to produce the cars in the quantity it promises. Model 3 numbers need to be in multiples of what they are producing right now. Wish them the best, will keep an eye as I am still not convinced that they can scale easily.

$VNO {{ '2016-10-28T18:26:59+0000' | timeago}} • Announcement

$VNO's Board of Trustees declared a regular quarterly dividend of $0.63 per common share. The dividend is payable on Nov. 21, 2016 to shareholders of record on Nov. 7, 2016.

$ABBV {{ '2016-10-28T18:24:35+0000' | timeago}} • Webcast

For 4Q16, $ABBV forecasts sales growth in excess of 20% for HUMIRA, which will contribute to the company's full year 2016 forecast of above 20%. The company continues to forecast HUMIRA international operational sales growth in the mid single digits for the full year.

$ABBV {{ '2016-10-28T18:21:43+0000' | timeago}} • Webcast

In 3Q16, $ABBV said HUMIRA's global sales were more than $4Bil, up 12.1% operationally. Globally, the company continues to see strong volume growth across all therapeutic segments. HUMIRA sales in the US grew 16.7% versus the prior year. The growth rate was negatively impacted by 4 points, due to higher customer ordering patterns in the prior year.

$ALXN {{ '2016-10-28T18:18:50+0000' | timeago}} • Webcast

$ALXN has almost 40 patients with ALXN1210, so the company has that deal of empiric data, which helps inform both the dose and interval. As it relates to the 8-week dosing interval, the company anticipates in the trials that the infusion time would be about two hours.

$ESS {{ '2016-10-28T18:16:50+0000' | timeago}} • Webcast

$ESS expects about a 20% drop in apartment supply in San Francisco and nearly 30% in San Jose in 2017 and fewer deliveries in each quarter in 2017. The company expects supply pressures to moderate in Northern California, especially in 2H17 assuming the job growth remains on track.